155 related articles for article (PubMed ID: 27402583)
1. Registered Randomized Trials Comparing Generic and Brand-Name Drugs: A Survey.
Flacco ME; Manzoli L; Boccia S; Puggina A; Rosso A; Marzuillo C; Scaioli G; Gualano MR; Ricciardi W; Villari P; Ioannidis JP
Mayo Clin Proc; 2016 Aug; 91(8):1021-34. PubMed ID: 27402583
[TBL] [Abstract][Full Text] [Related]
2. Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.
van der Meersch A; Dechartres A; Ravaud P
PLoS One; 2011; 6(8):e23611. PubMed ID: 21858184
[TBL] [Abstract][Full Text] [Related]
3. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
Borgheini G
Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
[TBL] [Abstract][Full Text] [Related]
4. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.
Kesselheim AS; Misono AS; Lee JL; Stedman MR; Brookhart MA; Choudhry NK; Shrank WH
JAMA; 2008 Dec; 300(21):2514-26. PubMed ID: 19050195
[TBL] [Abstract][Full Text] [Related]
5. Non-publication and delayed publication of randomized trials on vaccines: survey.
Manzoli L; Flacco ME; D'Addario M; Capasso L; De Vito C; Marzuillo C; Villari P; Ioannidis JP
BMJ; 2014 May; 348():g3058. PubMed ID: 24838102
[TBL] [Abstract][Full Text] [Related]
6. Generic versus brand-name drugs used in cardiovascular diseases.
Manzoli L; Flacco ME; Boccia S; D'Andrea E; Panic N; Marzuillo C; Siliquini R; Ricciardi W; Villari P; Ioannidis JP
Eur J Epidemiol; 2016 Apr; 31(4):351-68. PubMed ID: 26620809
[TBL] [Abstract][Full Text] [Related]
7. Brand name versus generic warfarin: a systematic review of the literature.
Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
[TBL] [Abstract][Full Text] [Related]
8. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
Rasmussen N; Lee K; Bero L
Trials; 2009 Dec; 10():116. PubMed ID: 20015404
[TBL] [Abstract][Full Text] [Related]
9. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
[TBL] [Abstract][Full Text] [Related]
10. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
[TBL] [Abstract][Full Text] [Related]
11. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
12. News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names.
Hochman M; Hochman S; Bor D; McCormick D
JAMA; 2008 Oct; 300(13):1544-50. PubMed ID: 18827211
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
14. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
Kwo EC; Kamat P; Steinman MA
Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
[TBL] [Abstract][Full Text] [Related]
15. The Role of Prescribing Generic (Non-proprietary) Drugs in the Prevalence of Therapeutic Inertia in Multiple Sclerosis Care.
Saposnik G; Mamdani M; Terzaghi M; Saladino ML; Silva B; Tobler PN; Caceres F
Front Neurol; 2018; 9():835. PubMed ID: 30369904
[No Abstract] [Full Text] [Related]
16. What's in a name? Use of brand versus generic drug names in United States outpatient practice.
Steinman MA; Chren MM; Landefeld CS
J Gen Intern Med; 2007 May; 22(5):645-8. PubMed ID: 17443372
[TBL] [Abstract][Full Text] [Related]
17. Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation.
Piovani D; Clavenna A; Cartabia M; Bortolotti A; Fortino I; Merlino L; Bonati M
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):121-8. PubMed ID: 24910387
[TBL] [Abstract][Full Text] [Related]
18. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
19. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
Kwong WJ; Kamat S; Fang C
Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
[TBL] [Abstract][Full Text] [Related]
20. Empirical evidence for outcome reporting bias in randomized clinical trials of acupuncture: comparison of registered records and subsequent publications.
Su CX; Han M; Ren J; Li WY; Yue SJ; Hao YF; Liu JP
Trials; 2015 Jan; 16():28. PubMed ID: 25626862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
